Markus Gershater’s Post

View profile for Markus Gershater, graphic

Chief Scientific Officer and Cofounder, Synthace

It's critical that experiments in discovery are as clinically relevant as possible. Part of this effort is making cell-based in vitro models as relevant as possible, which can involve addressing very challenging variability and complexity. Join Kavita R. tomorrow as she takes us through her work at GSK where she was looking to develop multicellular cardiac models to test for cardiotoxicity. We're talking DOE, Synthace, SPT Labtech Dragonfly, and cells spontaneously starting to beat in multiwell plates. What's not to love? Maryia Karpiyevich, PhD and I will also be there. :) https://lnkd.in/dFK-SBYy #DOEforBiology #Automation #DrugDiscovery

  • No alternative text description for this image
Erika Wiseman

Field Application Scientist at Synthace

4mo

So cool. Love to see DOE + phenotyping!

Avi Ladwa

B2B SaaS Life Sciences R&D | Digital, Data & Automation Strategy

4mo

Looking forward to learning more about this tomorrow

Brendan Cherrey

Scientific Solutions Consultant at Synthace

4mo

Looking forward to this!

Matt Philbin

Sales Development Leader

4mo

Can't wait to watch tomorrow!

Steven Richard Brown

Senior Research Scientist at Synthace Limited

4mo

Will be great to learn more about the application of DoE to this biological application!

Magda Misiorny

Scaling Tech Brands Worldwide | Marketing I Techstars & CEMS grad

4mo

this post in 1 word Markus ? 😉

See more comments

To view or add a comment, sign in

Explore topics